AcelRx Pharmaceuticals Inc. (ACRX)

2.35
0.00 (0.00)
NASDAQ : Health Technology
Prev Close 2.35
Open 2.33
Day Low/High 2.25 / 2.46
52 Wk Low/High 1.65 / 5.05
Volume 1.96M
Avg Volume 3.20M
Exchange NASDAQ
Shares Outstanding 76.39M
Market Cap 186.40M
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Read All About It! Positive News on Four Positions

We still like all of these names after developments this week.

Stocks Under $10 Weekly Summary

During the week we scaled into two existing positions and added back shares of a former holding.

Stocks Under $10 Weekly Summary

During the week we added to our cannabis play Kush Bottles and took a nice win on J.Jill.

Stocks Under $10 Weekly Summary

Last week we trimmed USA Technologies and added LendingClub to the Bullpen.

Trimming This Specialty Pharmaceutical Name

ACRX has reached our price target, so we’re being disciplined.

Stocks Under $10 Weekly Summary

We trimmed one position for a hefty gain last week, as the portfolio delivered very favorable performance on both an absolute and relative basis.

Stocks Under $10 Weekly Summary

We added 2 new positions during a week of solid performance for the portfolio.

Stocks Under $10 Weekly Summary

We added to three positions during a mixed week for the market.

Stocks Under $10 Weekly Summary

During a down week for the market, we exited one name and added to another.

Finally Significant News on a Health Care Position

Here’s our plan for AcelRx Pharmaceuticals leading up to earnings.

Stocks Under $10 Weekly Summary

We initiated one position and closed out another last week.

Stocks Under $10 Weekly Summary

We added to two positions during a week when nearly all of our holdings moved higher.

Stocks Under $10 Weekly Summary

We exited one name and added to another during a wild week for stocks.

Stocks Under $10 Weekly Summary

The portfolio had several market outperformers last week and we took some profits in one high-flying position.

Stocks Under $10 Weekly Summary

We added 2 Bullpen names during a challenging week for the market.

Stocks Under $10 Weekly Summary

During a ‘noisy’ week for the portfolio, we added a small speculative position in a payment-processing name.

Trimming One Position, Adding to Another

We will sell shares of AcelRx Pharmaceuticals and buy more Black Box.

Stocks Under $10 Weekly Summary

The strength exhibited by the Russell 2000 paved the way for portfolio last week.

Everything Is Coming Up Roses

New price target on Kush Bottles plus a rocking employment report.

Stocks Under $10 Weekly Summary

We threw in the towel last week on 2 positions and initiated a small stake in an ancillary cannabis play.

Stocks Under $10 Weekly Summary

During a shortened trading week we closed out of one position and added to another after earnings reports.

Stocks Under $10 Weekly Summary

We shed two positions last week as the market roared back.

Stocks Under $10 Weekly Summary

We added to several positions on weakness during a challenging last week for the stock market.

Stocks Under $10 Weekly Summary

We exited one position and added to another as volatility returned to the stock market last week.

Stocks Under $10 Weekly Summary

It was a mixed week for the portfolio as we trimmed one position and added to the Bullpen.

Stocks Under $10 Weekly Summary

Last week, we closed a position for a large gain and used some of the proceeds to start a small stake in a fracking and desalination name.

Stocks Under $10 Weekly Summary

We added two new positions to the portfolio last week.

Stocks Under $10 Weekly Summary

Despite a shortened trading week, we made a series of moves, including initiating a position in GSV Capital.

Stocks Under $10 Weekly Summary

During a quiet week for the market, we added to two positions and trimmed three others.

Adding to and Trimming Different Biotechs

We will buy more AcelRx Pharmaceuticals and sell shares of Inovio Pharmaceuticals as we close out 2017.

TheStreet Quant Rating: D- (Sell)